Evidence That an APOE Ε4 'Double Whammy' Increases Risk for Alzheimer's Disease

BMC Medicine - United Kingdom
doi 10.1186/1741-7015-10-36
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Environmental Factors Influencing the Link Between APOE Ε4 and Alzheimer's Disease (AD) Risk

International Psychogeriatrics
PsychiatryClinical PsychologyGerontologyGeriatricsMental Health
2018English

APOE Ε4 and Risk for Alzheimer's Disease: Do Regionally Distributed White Matter Hyperintensities Play a Role?

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2014English

More Evidence That Gum Disease Increases Cancer Risk

Cancer
Cancer ResearchOncology
2018English

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE Ε4 Non-Carriers

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2019English

APOE Ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons

Journal of Neuropsychiatry and Clinical Neurosciences
MedicinePsychiatryMental HealthNeurology
2015English

Apolipoprotein E Ɛ4 Allele Increases Risk for Psychotic Symptoms in Alzheimer's Disease

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2006English

Cystic Fibrosis Double Whammy

Science
MultidisciplinaryPhilosophy of ScienceHistory
2011English

Considering the APOE Locus in Polygenic Scores for Alzheimer's Disease

2019English

Common BACE2 Polymorphisms Are Associated With Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE Ε4 Non-Carriers

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy